Baron Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,347
Closed -$265K 247
2025
Q1
$265K Buy
4,347
+18
+0.4% +$1.05K 0.12% 147
2024
Q4
$245K Buy
4,329
+268
+7% +$15K 0.12% 149
2024
Q3
$210K Buy
+4,061
New +$191K 0.1% 187

Other funds holding BMY

Baron Wealth Management's BMY Position: Q2 2025 in Review

Baron Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 4,347 shares — an estimated $265K sold.

Baron Wealth Management first reported a position in BMY in Q3 2024 and held it in 3 quarters. The position peaked at $265K in Q1 2025. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Baron Wealth Management reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • Baron Wealth Management sold 4,347 Bristol-Myers Squibb shares in Q2 2025, an estimated $265K.
  • Baron Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2024 and held it in 3 quarters.
  • Baron Wealth Management's Bristol-Myers Squibb position peaked at $265K in Q1 2025.
  • 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Baron Wealth Management's 13F filing for Q2 2025, filed 9 Jul 2025.